Friday, November 23, 2012 Thursday, November 22, 2012 Wednesday, November 21, 2012- 3 Things to Watch With Sagent Pharmaceuticalsat Motley Fool (Wed, Nov 21)
- Adults With ADHD Commit Fewer Crimes When Medicatedat Bloomberg (Wed, Nov 21)
- Big Pharma's Safest Diabetes Playat Motley Fool (Wed, Nov 21)
- Pfizer's Xeljanz Gets Approval, While Lilly's Baricitinib Looks Strongat Seeking Alpha (Wed, Nov 21)
- CHMP Positive on Sanofi's LyxumiaZacks (Wed, Nov 21)
- Pfizer's Lyrica Scores in StudyZacks (Wed, Nov 21)
- Revisiting Buyout Rumors After Teva's CEO Shifts Focus To 'Smaller Acquisitions'at Seeking Alpha (Wed, Nov 21)
- Painful! Pfizer's Batting .500at Motley Fool (Wed, Nov 21)
- Why Honest Short Sellers Despise Insider Tradersat Forbes (Wed, Nov 21)
- The Zacks Analyst Blog Highlights: Incyte, Eli Lilly, Johnson & Johnson, Abbott Laboratories and Express Scripts HoldingZacks (Wed, Nov 21)
Tuesday, November 20, 2012 Monday, November 19, 2012- Data on Pfizer's LyricaZacks (Mon, Nov 19)
- Pfizer: Win Some, Lose Someat Motley Fool (Mon, Nov 19)
- AUXL Downgraded to UnderperformZacks (Mon, Nov 19)
- Eli Lilly And Company (LLY): Today's Featured Drugs Winnerat TheStreet (Mon, Nov 19)
- Eli Lilly Now #51 Largest Company, Surpassing Boeingat Forbes (Mon, Nov 19)
- Is This the Best Dividend in Biotech?at Motley Fool (Mon, Nov 19)
- Novo Nordisk A/S: Catching The Increasing Diabetes Trendat Seeking Alpha (Mon, Nov 19)
- J&J Ponders Elan Tie While Alzheimer Drug Future Reviewedat Bloomberg (Mon, Nov 19)
Add LLY News to My Yahoo!   | |
|
0.60(1.10%) May 24, 4:00PM EDT|After Hours
:
54.14 0.00 (0.00%) May 24, 5:42PM EDT